Procedure
Transpyloric vs Gastric Feeding for Bronchopulmonary Dysplasia
This trial aims to see if feeding premature infants with bronchopulmonary dysplasia directly into the small intestine (transpyloric tube feeding) is better than feeding into the stomach (ga
Proton Pump Inhibitor
AR Formula vs Omeprazole for Infant Acid Reflux
This trial aims to study the effects of three different treatments on infants diagnosed with GERD in the NICU. The treatments being compared are natural maturation, proton pump inhibitors (PPIs), and
Device
Omega-Cuff Device for GERD
This trial is testing the Omega-Cuff, a device that helps prevent acid reflux by supporting the muscle at the bottom of the esophagus. It is for GERD patients who don't get relief from medications. The device increases pressure to stop acid from coming up but still lets food go down easily.
Popular Filters
Trials for Peptic Ulcer Patients
Behavioural Intervention
Cognitive Behavioral Therapy for Acid Reflux
This trial tests a new therapy called eCBT+ for patients with GERD who don't respond well to usual treatments. The therapy helps reduce stress and focus on symptoms by changing how patients think and behave. The goal is to see if this approach can improve their quality of life.
Trials With No Placebo
Procedure
PRP in Hiatal Hernia Repair
This trial is testing whether using platelet rich plasma (PRP) with mesh in hiatal hernia surgery can improve healing and reduce hernia recurrence. The study involves adults with large hernias and looks at the effects of PRP on healing and recurrence rates. PRP is believed to enhance tissue healing, making the repair stronger. Platelet-rich plasma (PRP) has been underinvestigated for improving hernia repair outcomes, but it may enhance healing and reduce recurrence rates.
View More Related Trials
Frequently Asked Questions
Introduction to gerd
What are the top hospitals conducting gerd research?
Gastroesophageal reflux disease (GERD) affects millions of people worldwide, causing discomfort and potentially leading to serious complications. In the quest for effective treatments, several top hospitals have emerged as leaders in conducting clinical trials dedicated to this condition. One such institution is Vanderbilt University Medical Center located in Nashville. With two ongoing GERD trials and a cumulative total of six trials carried out over the years, Vanderbilt has been actively involved in researching this disorder since recording its first trial back in 2005.
Additionally, Mayo Clinic Florida situated in Jacksonville has also made significant contributions to GERD research. Currently conducting one active trial and having completed two previous investigations, Mayo Clinic Florida recorded its inaugural trial targeting GERD symptoms just ten years ago in 2012.
Further north, the Medical College of Wisconsin based in Milwaukee stands out with its commitment to advancing knowledge about GERD through clinical trials. This esteemed institution boasts one ongoing trial focused on this condition while having conducted two additional studies since their pioneering endeavor commenced in 2011.
Meanwhile, Reza Shaker Hospital located within Milwaukee mirrors the dedication towards investigating new avenues for treating GERD with one currently active clinical trial alongside an accomplished history of one prior study dating back only seven years ago to 2014.
Lastly but not least Kansas City VA Hospital playing a crucial role by dedicating itself into thoroughly studying gerd's varied dimensions; it sets off with scheduling on-going investigation focusing solely into addressing Gerd related issues joining hands together along-with other major institutions contributing greatly creating milestones furthering our understanding regarding finding practical approaches that will benefit patients around globe starting from2022 onwards
These esteemed hospitals are at the forefront of groundbreaking research aimed at improving outcomes for those affected by GERD. Their tireless efforts pave the way for potential breakthroughs that may revolutionize treatment options and provide much-needed relief for individuals living with this chronic condition
Which are the best cities for gerd clinical trials?
In the realm of GERD clinical trials, several cities have emerged as prominent hubs for research and innovation. Nashville, Tennessee; Atlanta, Georgia; Miami, Florida; Jacksonville, Florida; and Milwaukee, Wisconsin all offer opportunities to participate in active studies investigating various treatments like BLI5100 High Dose, Dexlansoprazole, Breath Test Evaluation for SIBO, commercially available lansoprazole, and more. With each city hosting multiple ongoing trials focused on advancing our understanding and management of GERD symptoms and complications.
Which are the top treatments for gerd being explored in clinical trials?
The search for effective treatments for GERD (gastroesophageal reflux disease) is an ongoing endeavor in clinical trials. Currently, several promising options are under investigation:
- EsoGuard: with 7 active trials and a total of 32 all-time GERD trials since its inception
- Baclofen: being explored in 5 ongoing clinical studies specifically targeting GERD
- LINX Reflux Management System: a popular option with 4 active trials dedicated to finding new insights into its effectiveness.
What are the most recent clinical trials for gerd?
Promising advancements in the field of gastroesophageal reflux disease (GERD) have emerged through recent clinical trials. One notable study focused on the effectiveness of BLI5100 at higher doses, aiming to provide improved outcomes for GERD patients. Another trial investigated a new drug product specifically designed to address the symptoms and underlying causes of GERD. Dexlansoprazole, another innovative treatment option, showed encouraging results in Phase 2 testing. Additionally, speech language therapy demonstrated potential benefits in managing GERD-related complications during both Phase 1 and Phase 2 trials. With these groundbreaking studies paving the way forward, individuals suffering from GERD can anticipate promising developments that may offer relief and improve their quality of life.
What gerd clinical trials were recently completed?
Recently, several significant clinical trials in the field of gastroesophageal reflux disease (GERD) have been completed. In May 2022 and January 2022, Phathom Pharmaceuticals successfully concluded separate trials evaluating the effectiveness of Vonoprazan for GERD treatment. Additionally, a trial sponsored by Northwestern University investigated dexlansoprazole for GERD management and was completed in July 2017. These studies contribute to the expanding body of knowledge surrounding GERD therapies, offering potential benefits to individuals affected by this common digestive disorder.